Business description
APONTIS PHARMA AG is a leading pharmaceutical company specializing in Single Pills in Germany. Single Pills combine two to three generic active ingredients in a single dosage form. APONTIS PHARMA develops, promotes and sells a broad portfolio of Single Pills and other pharmaceutical products, with a special focus on cardiovascular diseases. Since 2013, APONTIS successfully launched several Single Pill products alone for cardiovascular indications such as hypertension, hyperlipidemia and secondary prevention. With its headquarters in Monheim am Rhein, APONTIS PHARMA is located in one of Europe’s leading pharmaceutical and chemical region.
Management board & Supervisory board
| CEO |
| Karlheinz Gast |
| Management board |
| Thomas Milz |
| Supervisory board |
| Dr. Matthias Wiedenfels, Christian Bettinger, Dr. Anna Lisa Picciolo-Lehrke, Dr. Edin Hadzic, Olaf Elbracht |
Company data
| Name: |
APONTIS PHARMA AG |
| Address: |
Alfred-Nobel-Str. 10,D-40789 Monheim |
| Phone: |
+49-2173-8955-4949 |
| Fax: |
+49-2173-8955-4941 |
| E-mail: |
info@apontis-pharma.de
|
| Internet: |
https://apontis-pharma.de |
| Industry: |
Healthcare |
| Sector: |
Pharmaceutical Industry |
| Sub sector: |
Pharmaceuticals |
| End of financial year: |
12-31 |
| Free Float: |
- |
| IPO date: |
2021-05-11 |
Investor relations
| Name: |
Sven Pauly |
| IR phone: |
+49-2173-8955-4900 |
| IR Fax: |
- |
| IR e-mail: |
ir@apontis-pharma.de
|
